Galectin Therapeutics, Inc.

( )
GALT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.56%423.330.0%$6024.94m
BNTXBioNTech SE -5.62%339.010.0%$1181.48m
NVAXNovavax, Inc. -4.47%226.9279.4%$901.81m
SNSSSunesis Pharmaceuticals, Inc. -3.67%8.390.7%$586.49m
AMGNAmgen, Inc. -1.95%215.111.4%$548.49m
REGNRegeneron Pharmaceuticals, Inc. -1.69%640.892.7%$486.09m
GILDGilead Sciences, Inc. -0.91%70.961.0%$430.39m
ILMNIllumina, Inc. -2.02%438.003.5%$397.21m
TECHBio-Techne Corp. -1.04%528.824.5%$352.26m
BIIBBiogen, Inc. -0.57%298.491.7%$304.57m
VRTXVertex Pharmaceuticals, Inc. -1.40%185.671.9%$238.22m
ISEEIVERIC bio, Inc. -2.41%16.220.0%$190.09m
BGNEBeiGene Ltd. -1.15%398.501.3%$184.03m
LIFEaTyr Pharma, Inc. -0.87%10.223.2%$142.93m
EXASEXACT Sciences Corp. -2.77%105.1518.1%$131.92m

Company Profile

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.